1994
DOI: 10.1136/oem.51.6.397
|View full text |Cite
|
Sign up to set email alerts
|

Occupational asthma in salbutamol process workers.

Abstract: Occupational asthma after exposure to salbutamol in the pharmaceutical industry has not been previously reported. The occurrence of occupational asthma is described in two pharmaceutical process workers who were likely to have inhaled doses appreciably in excess of the therapeutic dose range. The findings do not lead to an unequivocal conclusion on the mechanism of the asthma but it was probably a pharmacological consequence of high exposure.ing samplers showed values ranging from 0 05 mg m-3 in the background… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

1995
1995
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…No less than 200 compounds that cause occupational asthma were known at the end of the 1980s and several further compounds with similar activity have been discovered more recently. During the first half of 1994 for instance, occupational asthma in workers involved in the manufacture of the drug salbutamol was recognised [9]. Also, the risk of asthma from exposure to bio-aerosols in the potato-processing industry [10] was described.…”
Section: Pharmacological Bronchoconstrictionmentioning
confidence: 99%
“…No less than 200 compounds that cause occupational asthma were known at the end of the 1980s and several further compounds with similar activity have been discovered more recently. During the first half of 1994 for instance, occupational asthma in workers involved in the manufacture of the drug salbutamol was recognised [9]. Also, the risk of asthma from exposure to bio-aerosols in the potato-processing industry [10] was described.…”
Section: Pharmacological Bronchoconstrictionmentioning
confidence: 99%
“…No less than 200 compounds that cause occupational asthma were known at the end of the 1980s and several further compounds with similar activity have been discovered more recently. During the first half of 1994 for instance, occupational asthma in workers in volved in the manufacture of the drug salbutamol was recognised [9], Also, the risk of asthma from exposure to bio-aerosols in the potato-processing industry [10] was described. High-molecular-weight materials, as a rule, cause IgE-mediated immediate reactions -i.e.…”
Section: Immunological Bronchoconstrictionmentioning
confidence: 99%
“…(1) report a case of bronchoconstriction in a patient caused by inhalation of short‐acting β2‐agonists. In an occupational setting, exposures to such agents can be even greater than those encountered therapeutically and there have been at least two reported cases of occupational asthma attributed to salbutamol exposure in pharmaceutical process workers (2). However, in the above‐mentioned report the authors postulated that the mechanism might be tachyphylactic rather than IgE‐mediated.…”
mentioning
confidence: 99%